Delivery Order SPE2DB22D9330-SPE2DB23FK8LH
Award Date 2/3/23
Potential Completion Date 2/6/23
Potential Value $813
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order on August 6, 2025, for 1,440 units of HAVRIX 1,440 Unit/ML syringes with a ceiling value of $2,268.40. This delivery order, issued without a set-aside designation, is part of the company's larger Indefinite Delivery Contract with the Defense Logistics Agency under the SPE2DB program, valued at $499.9 million through November 2026. The contract is...
- DMS Pharmaceutical Group Inc. was awarded a four hundred six dollar firm fixed price delivery order for 1,440 unit/ml syringes of HAVRIX vaccine. The contract has no set-aside designation and is being awarded by the Defense Logistics Agency to fulfill their vaccine requirements. Performance will occur in Park Ridge, Illinois with delivery by January 6, 2023. As the Defense Logistics Agency is responsible for worldwide logistics support of the Department of Defense, this contract will help the...
- The Defense Logistics Agency awarded an $813 firm fixed price delivery order to DMS Pharmaceutical Group Inc. of Park Ridge, Illinois. The order is for 1,440 units of HAVRIX vaccine in 1 ml pre-filled syringes with an anticipated completion date of September 21, 2023. No set-aside provision was specified in the award. The order was issued under an unspecified agency-wide indefinite-delivery/indefinite-quantity contract vehicle to support the DLA's medical supply chain requirements. DMS...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, received a firm fixed-price delivery order from the Defense Logistics Agency (DLA) on August 27, 2025, for HAVRIX 720 Unit/0.5 ML syringes valued at $2,168.80. This delivery order was issued without a set-aside designation and carries an ultimate completion date of August 28, 2025, with performance to be completed at the awardee's Park Ridge, Illinois location. HAVRIX is a...
- This delivery order, valued at $9,073.60, was awarded on August 4, 2025, to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of HAVRIX 1,440 unit/mL syringes. The award represents a firm fixed-price delivery order with an ultimate completion date of August 7, 2025, and was funded by the Defense Logistics Agency's Medical Supply Chain division. This contract carries no set-aside designation, allowing DMS...
- The Defense Logistics Agency (DLA) Medical Supply Chain division awarded a delivery order valued at $2,268.40 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, on September 10, 2025. The delivery order calls for 1,440 units per milliliter of Havrix, a hepatitis A vaccine, to be delivered by September 15, 2025. This firm fixed-price delivery order was issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at two thousand four hundred forty dollars and eight cents to DMS Pharmaceutical Group Inc. to supply one thousand four hundred forty units of HAVRIX, a hepatitis A vaccine presented as one milliliter pre-filled syringes. Performance will take place in Park Ridge, Illinois over a one day period from February 16 to 17, 2023. The DLA procures medical supplies and equipment to support Department of Defense programs....
- <p>This delivery order, awarded by the Defense Logistics Agency to DMS Pharmaceutical Group Inc., is for the delivery of 1,440 units of HAVRIX vaccine in 1 ml syringes. The potential value of this firm fixed price contract is $2,033.40. Performance will occur in Park Ridge, Illinois, with delivery required no later than January 25, 2023. No set-aside provisions were applied to this award in support of the Defense Logistics Agency's medical supply chain responsibilities.</p>
- The Defense Logistics Agency awarded a $1,220 firm fixed price delivery order to DMS Pharmaceutical Group Inc. to supply 1,440 units of HAVRIX vaccine in pre-filled syringes. The vaccine will be delivered to a location in Park Ridge, Illinois by February 13, 2023 to support the Department of Defense's immunization programs. No subcontractors or set aside designations were identified. The delivery order was issued against an existing DLA pharmaceuticals contract vehicle to fulfill vaccine...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at $3,253.44 to DMS Pharmaceutical Group Inc. of Park Ridge, Illinois. Under the contract, DMS Pharmaceutical Group will provide 1,440 units of HAVRIX, a hepatitis A vaccine, to the Defense Logistics Agency by February 6, 2023. The place of performance is listed as the prime contractor's location in Park Ridge. No additional context was provided regarding the Defense Logistics Agency's programs or any associated...